MARKET

TMBRQ

TMBRQ

Trex Wind-Down
EXMKT
0.0001
NaN%
Closed 09:30 07/15 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.390
52 WEEK LOW
0.0001
MARKET CAP
343.27
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TMBRQ last week (0708-0712)?
Weekly Report · 12h ago
Weekly Report: what happened at TMBRQ last week (0701-0705)?
Weekly Report · 07/08 11:37
Weekly Report: what happened at TMBRQ last week (0624-0628)?
Weekly Report · 07/01 11:38
Weekly Report: what happened at TMBRQ last week (0617-0621)?
Weekly Report · 06/24 11:46
Weekly Report: what happened at TMBRQ last week (0610-0614)?
Weekly Report · 06/17 11:36
Weekly Report: what happened at TMBRQ last week (0603-0607)?
Weekly Report · 06/10 11:39
Weekly Report: what happened at TMBRQ last week (0527-0531)?
Weekly Report · 06/03 11:42
Weekly Report: what happened at TMBRQ last week (0520-0524)?
Weekly Report · 05/27 11:48
More
About TMBRQ
Timber Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of treatments for orphan dermatologic diseases. The Company is also focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), including X-linked recessive CI (XLRI) and autosomal recessive CI (ARCI) and other sclerotic skin diseases. Its lead late-stage program is TMB-001. TMB-003 is its earliest stage program. TMB-001 is a topical formulation of isotretinoin using its patented IPEG delivery system, completed its Phase IIb clinical trial for the treatment of moderate to severe subtypes of CI. The earliest stage product in its pipeline is TMB-003, a formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist. It is in preclinical development as a locally applied formulation for the treatment of sclerotic skin diseases.

Webull offers Timber Pharmaceuticals Inc stock information, including EXMKT: TMBRQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMBRQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TMBRQ stock methods without spending real money on the virtual paper trading platform.